Table 1.
The base characteristics and clinical symptoms of positive COVID-19 participants.
| n/mean | % | |
|---|---|---|
| Base characters | ||
| Age (year) | 32.32 ± 15.71 | |
| Duration of symptom (day) | 3.50 ± 1.03 | |
| Male | 24 | 64.90% |
| Clinical symptoms | ||
| Fever (Y) | 19 | 51.40%* |
| Dry cough (Y) | 5 | 13.50% |
| Expectoration (Y) | 10 | 27.00% |
| Pharyngalia (Y) | 4 | 10.80% |
| Pharynoxerosis (Y) | 3 | 8.10% |
| Rhinobyon (Y) | 5 | 13.50% |
| Running nose (Y) | 3 | 8.10% |
| Hypodynamic (Y) | 8 | 21.60% |
| Muscular soreness (Y) | 6 | 16.20% |
| Diarrhea (Y) | 1 | 2.70% |
| No symptom | 6 | 16.20% |
| Blood routine index | % | |
| PDW percentage | ||
| Up | 2 | 5.40% |
| Down | 33 | 89.20%* |
| MPV (fl) | ||
| Up | 1 | 2.7% |
| Down | 30 | 81.10%* |
| Eosinophils percentage | ||
| Up | 0* | 0 |
| Down | 17 | 45.90%* |
| Lung CT imaging | ||
| Pneumonia | 30 | 81.10%* |
| Bilateral lesion | 15 | 40.50% |
| Superior lobe lesion | 13 | 35.10% |
| Mid-lobe lesion | 7 | 18.90% |
| Inferior lobe | 20 | 54.10% |
| Over-one-lobe lesion | 14 | 37.80% |
| With pulmonary nodule | 8 | 21.60% |
| Over-one lesion | 16 | 43.20% |
| Over-ten lesion | 8 | 21.60% |
| White-lung imaging | 2 | 5.40% |
| No lesion | 10 | 27.02% |
(Y), positive; in one case over-one symptom occurred, thus adding up all numbers not equal to 37; Over-one lobe lesion, lesion over one pulmonary lobe; over-one lesion, the number of pulmonary lesion over one; over-ten lesion, the number of pulmonary lesion over ten; superior lobe lesion, the superior lobe affected; mid-lobe lesion, the mid-lobe affected; inferior lobe lesion, the inferior lobe affected.
*
Statistically significant.